Purification, Renaturation, and Stability Study of FlaA Protein

Jiecheng Li; Xiaohong Jian; Zhi Zhang; Zaixin Li

doi:10.62051/ijphmr.v6n4.03

Authors

Jiecheng Li
Xiaohong Jian
Zhi Zhang
Zaixin Li

DOI:

https://doi.org/10.62051/ijphmr.v6n4.03

Keywords:

Helicobacter pylori, FlaA protein, Inclusion body renaturation, Dialysis renaturation, Ultrafiltration renaturation, Protein stability

Abstract

Objective: To establish an efficient purification and renaturation process for Helicobacter pylori flagellin A (FlaA) and to investigate its storage stability. Methods: Recombinant Escherichia coli cells were disrupted by high-pressure homogenization. Inclusion bodies were purified by washing with Triton X-100 and low-concentration urea. Single-factor experiments were conducted to optimize initial protein concentration, pH, temperature, and the concentrations of glycine, arginine, and glycerol during dialysis renaturation. Furthermore, an ultrafiltration-dialysis combined renaturation process was established. The Bradford method was used to monitor protein concentration changes to evaluate storage stability. Results: High-pressure homogenization effectively disrupted bacterial cells. After purification, the purity of FlaA protein exceeded 90%. The optimal conditions for dialysis renaturation were 0.1 mol/L glycine and 0.3 mol/L arginine, yielding a renaturation recovery of 80.67%. The ultrafiltration-dialysis combined renaturation achieved a recovery of 75.32% while significantly reducing processing time. Storage at a protein concentration of 0.5 mg/mL resulted in the slowest degradation rate at low temperature. Conclusion: This study establishes an efficient and economical process for the purification and renaturation of FlaA inclusion bodies, providing technical support for the large-scale preparation of anti-H. pylori egg yolk antibodies.

References

[1] MALFERTHEINER P, CAMARGO M C, EL-OMAR E, et al. Helicobacter pylori infection [J]. Nature Reviews Disease Primers, 2023, 9(1): 19.

[2] BANISEFID E, NASIRI E, POUREBRAHIMIAN LEILABADI S, et al. The paradox of Helicobacter pylori: how does H. pylori infection protect against esophageal cancer? [J]. 2024, 86(12): 7221-6.

[3] ZHANG L, XIAO Y, JI L, et al. Potential Therapeutic Effects of Egg Yolk Antibody (IgY) in Helicobacter pylori Infections─A Review [J]. Journal of Agricultural and Food Chemistry, 2021, 69(46): 13691-9.

[4] GU H. Role of Flagella in the Pathogenesis of Helicobacter pylori [J]. Current microbiology, 2017, 74(7): 863-9.

[5] NI H, GUO P C, JIANG W L, et al. Expression of nattokinase in Escherichia coli and renaturation of its inclusion body [J]. Journal of biotechnology, 2016, 231: 65-71.

[6] KARAKAŞ F, ARSLANOĞLU A. Gene cloning, heterologous expression, and partial characterization of a novel cold-adapted subfamily I.3 lipase from Pseudomonas fluorescence KE38 [J]. Sci Rep, 2020, 10(1): 22063.

[7] SOLEYMANI B, BARZEGARI E, MANSOURI K, et al. Heterologous expression, purification, and refolding of SRY protein: role of L-arginine as analyzed by simulation and practical study [J]. Molecular biology reports, 2020, 47(8): 5943-51.

[8] ZHANG Y N, LIU J J, ZHANG W, et al. Expression, purification and refolding of pro-MMP-2 from inclusion bodies of E. coli [J]. Protein Expression and Purification, 2023, 208-209: 106278.

[9] DEL GIUDICE A, DEL GIUDICE D, SPATOLA E, et al. An albumin unfolding and refolding cycle induced by a time-controlled pH jump [J]. Organic & biomolecular chemistry, 2024, 23(1): 118-25.